Is Jazz Pharmaceuticals Going To Be Bought Out?

Dublin based Jazz Pharmaceuticals plc (NASDAQ:JAZZ) has seen its share price rise steadily since the beginning of January, fueling speculation that the company may be about to become the target of a takeover bid. Hardly surprising when you consider the number of pharmaceutical giants from around the world that have been sniffing around various Irish firms due to the low corporate Irish tax rate. Indeed, the trend hasn’t gone unnoticed. Timothy Chiang, an analyst at CRT Capital Groups, was prompted to label the phenomenon “a feeding frenzy.” 2013 saw several deals go through. New Jersey firm, Actavis plc (NYSE:ACT), bought Dublin…